June 2026– date –
-
New Technology
Genomics Launches AI Platform “Mystra AI” to Streamline Drug Discovery Utilizing Genome-Phenotype Data
Biology Digital UK Overview Genomics has unveiled "Mystra AI," an AI platform leveraging advanced machine learning models trained on extensive genome-phenotype data to streamline drug discovery. Primarily focused on drug discovery, this ... -
New Technology
NTHRYS Biotech Labs Unveils AI DoE Automation Software Suite, Accelerating Media Optimization and Bioprocess Development
NTHRYS Biotech Labs Germany Overview NTHRYS Biotech Labs has launched an AI-powered software suite for bioprocess development, featuring AI Design of Experiment (DoE) automation for media formulation and screening. This tool predicts opt... -
Cell Culture Technology
Miltenyi Biotec Builds Scalable Global T-Cell Manufacturing Platform Using Automated, Closed Systems
Bioprocess Online / Miltenyi Biotec Germany Overview Miltenyi Biotec is actively developing a scalable global T-cell manufacturing platform that leverages automated, closed systems. The strategy emphasizes integrating six critical produc... -
Market Trends
Pharmaceutical CDMO Market Report: Capital Investments and Advanced Therapies Drive Growth
Global Market Insights Global Overview This article provides an overview of the Pharmaceutical CDMO Market research report published by Global Market Insights. The report highlights significant capital investments and major expansions wi... -
New Technology
Real-Time Monitoring Tools Advance Bioreactor Scale-Up, Integrating Digital Twins and PAT for Enhanced Efficiency
Cellbase Global Overview To efficiently scale up bioreactors, real-time monitoring tools—including electrochemical and optical sensors, PAT instruments like Raman and NIR spectroscopy, and capacitance probes for live cell density—are rap... -
Cell Culture Technology
Engineered Allogeneic Treg Cell Therapy TRX103 Enters Phase 1/2a Clinical Trials for Crohn’s Disease and GvHD Prevention
Frontiers Global Overview The gene-edited allogeneic Treg cell therapy candidate TRX103, designed as a scalable, off-the-shelf application, has commenced Phase 1/2a clinical evaluation for Crohn's disease and Graft-versus-Host Disease (G... -
Market Trends
Cell Therapy Startups Like Orca Bio and Allogene Lead Cancer & Autoimmune Disease Treatment with Off-the-Shelf Platforms
New Market Pitch USA Overview Cell therapy startups such as Orca Bio and Allogene, utilizing off-the-shelf platforms, are spearheading advancements in allogeneic and iPSC-derived therapies for cancer and autoimmune diseases. Key differen... -
New Technology
Raman Spectroscopy Outperforms NIR in Bioprocess Monitoring, Offering Enhanced Metabolite Selectivity with Reduced Water Interference
Technology Networks Global Overview In real-time bioprocess monitoring, Raman spectroscopy demonstrates superior selectivity for metabolites like glucose and lactate in cell cultures compared to Near-Infrared (NIR) spectroscopy, due to i... -
New Technology
Smart Composting Research Achieves Emission Reductions and Yield Boosts with AI and Digital Twins, Demonstrating Versatility for Bioprocess Optimization
CAS USA Overview New CAS research reports that a smart composting system, powered by AI and machine learning, has achieved reduced emissions and boosted yields. This system shifts composting from empirical operations to predictive and pr... -
Market Trends
Genedata Establishes New Standard for Biopharma Quality Control with NGS, Ensuring Genetic Stability in CGT
Genedata Switzerland Overview Genedata highlights Next-Generation Sequencing (NGS) as a powerful analytical tool for biopharmaceutical quality control (QC). NGS offers GxP-compliant workflows and supports data integrity and streamlined c...